0001189727-15-000002.txt : 20150213
0001189727-15-000002.hdr.sgml : 20150213
20150213180223
ACCESSION NUMBER: 0001189727-15-000002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150211
FILED AS OF DATE: 20150213
DATE AS OF CHANGE: 20150213
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ICU MEDICAL INC/DE
CENTRAL INDEX KEY: 0000883984
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330022692
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92763-6212
BUSINESS PHONE: 949-366-2183
MAIL ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92763-6212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BURCAR ALISON D
CENTRAL INDEX KEY: 0001189727
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34634
FILM NUMBER: 15616767
MAIL ADDRESS:
STREET 1: C/O ICU MEDICAL INC
STREET 2: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92673
FORMER NAME:
FORMER CONFORMED NAME: BRUMMETT BURCAR ALISON
DATE OF NAME CHANGE: 20020916
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2015-02-11
0
0000883984
ICU MEDICAL INC/DE
ICUI
0001189727
BURCAR ALISON D
951 CALLE AMANECER
SAN CLEMENTE
CA
92673
0
1
0
0
Vice President and Gen'l Mgr.
Common Stock
0.0
2015-02-11
4
A
0
3549.0
0.0
A
2018-02-11
Common Stock
3549
3549
D
Non-Qualified Stock Option (right to buy)
88.76
2015-02-11
4
A
0
13219.0
88.76
A
2025-02-11
Common Stock
13219
13219
D
These securities are Restricted Stock Units.
There is neither a purchase price nor an exercise price for the Restricted Stock Units.
One third of the Units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.
One-third of the shares shall vest on each of the first, second, and third anniversaries of the grant date. The vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and thirty percent of the exercise price per share for thirty consecutive trading days. The appreciation must occur within four years from the grant date.
By: Lynn Ehrhart For: Alison D. Burcar
2015-02-13